<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000za 4500</marc:leader>
    <marc:controlfield tag="001">9.812533</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20221107141340</marc:controlfield>
    <marc:controlfield tag="007">cr |||||||||||</marc:controlfield>
    <marc:controlfield tag="008">170222s2016    onca    o    f100 0 eng d</marc:controlfield>
    <marc:datafield tag="020" ind1=" " ind2=" ">
      <marc:subfield code="a">978-0-660-04805-5</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">MR4-48/2016E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="111" ind1="2" ind2=" ">
      <marc:subfield code="a">Human Immunology Consensus Workshop</marc:subfield>
      <marc:subfield code="d">(2014 :</marc:subfield>
      <marc:subfield code="c">Toronto, Ont.)</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="1" ind2="0">
      <marc:subfield code="a">Human Immunology Consensus Workshop </marc:subfield>
      <marc:subfield code="h">[electronic resource] : </marc:subfield>
      <marc:subfield code="b">November 25th and 26th 2014, Sheraton Toronto Airport Hotel &amp; Conference Centre, Toronto, On / </marc:subfield>
      <marc:subfield code="c">[written by Isabelle Létourneau].</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="260" ind1=" " ind2=" ">
      <marc:subfield code="a">Ottawa : </marc:subfield>
      <marc:subfield code="b">Canadian Institutes of Health Research, </marc:subfield>
      <marc:subfield code="c">c2016.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">39 p. : </marc:subfield>
      <marc:subfield code="b">col. ill.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in French under title: Atelier de consultation sur l'immunologie humaine : 25 et 26 novembre 2014, Sheraton Toronto Airport Hotel &amp; Conference Centre, Toronto (Ont.).</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Cover title.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"Written by: Isabelle Létourneau, PhD"--p. [2].</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">"The Canadian Institute of Health Research (CIHR), Canada’s premier health research funding agency, is comprised of 13 virtual Institutes – one of which is the Institute of Infection and Immunity (III). In 2010, the Institute’s Advisory Board identified human immunology as a field in which strategic investment could have a significant impact in terms of knowledge and clinical outcomes. A consultation workshop was held to inform III and partner Institutes how best to strategically invest in human immunology research in Canada. Seventy-five participants represented research, research management and support or the pharmaceutical industry from across Canada, and included 2 International participants. The goals of the workshop were to stimulate discussion among the community; identify their needs; and hear from experts in human immunology on their work and perspectives regarding the state of research in terms of needs for moving forward. The workshop provided a forum to gather recommendations on how best to address current challenges, respond to the needs of the research community and have a positive impact on the health of Canadians”--Executive summary, p. 4.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="530" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in print format.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Health</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Medical research</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="700" ind1="1" ind2=" ">
      <marc:subfield code="a">Létourneau, Isabelle,</marc:subfield>
      <marc:subfield code="d">1978-</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="2" ind2=" ">
      <marc:subfield code="a">CIHR Institute of Infection and Immunity (Canada)</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Atelier de consultation sur l'immunologie humaine </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.812535</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="776" ind1="0" ind2="#">
      <marc:subfield code="t">Human Immunology Consensus Workshop </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.812532</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">2.13 MB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2017/irsc-cihr/MR4-48-2016-eng.pdf</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
